RE:RE:RE:RE:RE:RE:RE:Again good news and a step closer to break out...and That's hard to say, since there are so many variables. As of now, ENW is mainly bringing in revenues from equipment sales and royalties from food products utilizing nutraREV technology. Although I think this is great, and will likely alone make the company profitable, I think there's more promise when they begin to diversify. What happens, for example, when powderREV technology becomes the new standard for manufacturing enzymes? What happens if REV technology finds industrial applications? Just imagine what would happen if bioREV gains market acceptance (It clearly shows why it could be a huge advantage over competitors)? I'm a firm believer that some of these things are going to happen, and in the meantime, the nutraREV commercial agreement list and machine instillations continue to grow. It's like watching something great grow from the very beginning.